Dynamic Medical Technologies Inc.

TPEX:4138 Stock Report

Market Cap: NT$3.4b

Dynamic Medical Technologies Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Dynamic Medical Technologies.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth22.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Know This Before Buying Dynamic Medical Technologies Inc. (GTSM:4138) For Its Dividend

Apr 19
Know This Before Buying Dynamic Medical Technologies Inc. (GTSM:4138) For Its Dividend

Dynamic Medical Technologies (GTSM:4138) Has Some Way To Go To Become A Multi-Bagger

Mar 29
Dynamic Medical Technologies (GTSM:4138) Has Some Way To Go To Become A Multi-Bagger

How Much Have Dynamic Medical Technologies (GTSM:4138) Shareholders Earned On Their Investment Over The Last Five Years?

Mar 08
How Much Have Dynamic Medical Technologies (GTSM:4138) Shareholders Earned On Their Investment Over The Last Five Years?

Are Poor Financial Prospects Dragging Down Dynamic Medical Technologies Inc. (GTSM:4138 Stock?

Feb 07
Are Poor Financial Prospects Dragging Down Dynamic Medical Technologies Inc. (GTSM:4138 Stock?

Should You Rely On Dynamic Medical Technologies's (GTSM:4138) Earnings Growth?

Jan 10
Should You Rely On Dynamic Medical Technologies's (GTSM:4138) Earnings Growth?

Will Dynamic Medical Technologies (GTSM:4138) Multiply In Value Going Forward?

Dec 20
Will Dynamic Medical Technologies (GTSM:4138) Multiply In Value Going Forward?

What Would Shareholders Who Purchased Dynamic Medical Technologies'(GTSM:4138) Stock Five Years Ago Be Earning on Their Investment Today?

Nov 29
What Would Shareholders Who Purchased Dynamic Medical Technologies'(GTSM:4138) Stock Five Years Ago Be Earning on Their Investment Today?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dynamic Medical Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:4138 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20241,56819794201N/A
6/30/20241,589197196291N/A
3/31/20241,603203260350N/A
12/31/20231,594210289361N/A
9/30/20231,574194277372N/A
6/30/20231,510176302389N/A
3/31/20231,376152240331N/A
12/31/20221,292137162277N/A
9/30/20221,202140136203N/A
6/30/20221,110134133190N/A
3/31/20221,050126146200N/A
12/31/20211,028123235278N/A
9/30/2021995113222264N/A
6/30/20211,019116251286N/A
3/31/20211,031119275293N/A
12/31/20201,009116240249N/A
9/30/20201,044120274307N/A
6/30/20201,068115194227N/A
3/31/20201,147120198232N/A
12/31/20191,178113235267N/A
9/30/20191,14198248263N/A
6/30/20191,156104251265N/A
3/31/20191,163105203218N/A
12/31/20181,165105131146N/A
9/30/20181,199117107127N/A
6/30/20181,194115N/A86N/A
3/31/20181,173113N/A105N/A
12/31/20171,157113N/A144N/A
9/30/20171,137111N/A87N/A
6/30/20171,144113N/A183N/A
3/31/20171,186114N/A227N/A
12/31/20161,215118N/A247N/A
9/30/20161,221118N/A283N/A
6/30/20161,285122N/A263N/A
3/31/20161,319127N/A292N/A
12/31/20151,314121N/A207N/A
9/30/20151,320126N/A319N/A
6/30/20151,297114N/A284N/A
3/31/20151,246111N/A335N/A
12/31/20141,204106N/A401N/A
9/30/20141,21296N/A270N/A
6/30/20141,10981N/A310N/A
3/31/20141,00754N/A226N/A
12/31/201389841N/A227N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4138's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if 4138's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4138's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4138's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 4138's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 4138's Return on Equity is forecast to be high in 3 years time


Discover growth companies